Robert T. Davis Jr. - Mar 6, 2024 Form 4 Insider Report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Signature
/s/ Eric Schwartz; Attorney-in-Fact
Stock symbol
IART
Transactions as of
Mar 6, 2024
Transactions value $
-$20,829
Form type
4
Date filed
3/8/2024, 04:22 PM
Previous filing
Feb 22, 2024
Next filing
Mar 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IART Common Stock Options Exercise $285K +8.74K +17.65% $32.59 58.2K Mar 6, 2024 Direct
transaction IART Common Stock Sale -$305K -8.35K -14.33% $36.59 49.9K Mar 6, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IART Non-Qualified Stock Option (right to buy) Options Exercise $0 -8.74K -100% $0.00* 0 Mar 6, 2024 Common Stock 8.74K $32.59 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold in connection with a broker-assisted "sell to cover" cashless exercise transaction to cover the exercise price and withholding taxes upon the exercise of stock options scheduled to expire.
F2 The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $36.57 to $36.65 The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
F3 25% of the stock options vested on the first, second, third and fourth anniversary of the original grant date of March 14, 2016.